melphalan pharmexon 50 mg
emcure pharma uk limited - marea britanie - melphalanum - pulb. si solv. pt. sol. inj./perf. - 50mg - agenti alchilanti analogi de nitrogen mustard
pepaxti
oncopeptides ab - melphalan flufenamide hydrochloride - mielom multiplu - agenți antineoplazici - pepaxti is indicated, in combination with dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least three prior lines of therapies, whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one anti-cd38 monoclonal antibody, and who have demonstrated disease progression on or after the last therapy. for patients with a prior autologous stem cell transplantation, the time to progression should be at least 3 years from transplantation (see section 4.
melphalan-ratiopharm 50 mg
sindan - pharma s.r.l. - romania - melphalanum - pulb.+solv. pt. sol. inj./perf. - 50mg - agenti alchilanti analogi de nitrogen mustard
melphalan hydrochloride 50 mg
cn unifarm s.a. - melphalanum - pulb+solv. pt. sol. inj./perf. - 50mg - agenti alchilanti analogi de nitrogen mustard
melphalan ratiopharm 50 mg
sindan pharma s.r.l. - romania - melphalanum - pulb+solv. pt. sol. inj./perf. - 50mg - agenti alchilanti analogi de nitrogen mustard
melphalan tillomed 50 mg
mias pharma limited - irlanda - melphalanum - pulb. si solv. pt. sol. inj./perf. - 50mg - agenti alchilanti analogi de nitrogen mustard
melfalan tillomed 50 mg
tillomed pharma gmbh - germania - melphalanum - pulb. si solv. pt. sol. inj./perf. - 50mg - agenti alchilanti analogi de nitrogen mustard
melfalan zentiva 50 mg
mias pharma limited - irlanda - melphalanum - pulb. si solv. pt. sol. inj./perf. - 50mg - agenti alchilanti analogi de nitrogen mustard
melfalan amring 50 mg
drehm pharma gmbh - austria - melphalanum - pulb.+solv. pt. sol. inj./perf. - 50mg - agenti alchilanti analogi de nitrogen mustard
alkeran 2 mg
excella gmbh - germania - melphalanum - compr. film. - 2mg - agenti alchilanti analogi de nitrogen mustard